MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

Cancer Statistics, 2007

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text

American Cancer Society, Cancer Statistics, Epidemiology +13

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.4K citations

Gene expression correlates of clinical prostate cancer behavior

Dinesh Singh, Phillip G. Febbo, Kenneth N. Ross et al. · Cancer Cell · 2002 · 2.5K citations · Full text

Urology, Medicine, Cancer Genomics +6

LNCaP model of human prostatic carcinoma.

Julius S. Horoszewicz, Susan S. Leong, Elzbieta Kawinski et al. · PubMed · 1983 · 1.8K citations

Urology, Developmental Biology, Lncap Cell Line +13